181 related articles for article (PubMed ID: 7877849)
1. A longitudinal study of naturally acquired cellular and humoral immune responses to a merozoite surface protein (MSP1) of Plasmodium falciparum in an area of seasonal malaria transmission.
Riley EM; Morris-Jones S; Blackman MJ; Greenwood BM; Holder AA
Parasite Immunol; 1993 Sep; 15(9):513-24. PubMed ID: 7877849
[TBL] [Abstract][Full Text] [Related]
2. Seasonal changes in the antibody responses against Plasmodium falciparum merozoite surface antigens in areas of differing malaria endemicity in Indonesia.
Supargiyono S; Bretscher MT; Wijayanti MA; Sutanto I; Nugraheni D; Rozqie R; Kosasih AA; Sulistyawati S; Hawley WA; Lobo NF; Cook J; Drakeley CJ
Malar J; 2013 Dec; 12():444. PubMed ID: 24321092
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to epitopes on merozoite and sporozoite surface antigens as serologic markers of malaria transmission: studies at a site in the dry zone of Sri Lanka.
Ramasamy R; Nagendran K; Ramasamy MS
Am J Trop Med Hyg; 1994 May; 50(5):537-47. PubMed ID: 7515593
[TBL] [Abstract][Full Text] [Related]
4. Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (PfMSP1) of Plasmodium falciparum are associated with reduced malaria morbidity.
Riley EM; Allen SJ; Wheeler JG; Blackman MJ; Bennett S; Takacs B; Schönfeld HJ; Holder AA; Greenwood BM
Parasite Immunol; 1992 May; 14(3):321-37. PubMed ID: 1625908
[TBL] [Abstract][Full Text] [Related]
5. Cellular and humoral immune responses to well-defined blood stage antigens (major merozoite surface antigen) of Plasmodium falciparum in adults from an Indian zone where malaria is endemic.
Kabilan L; Sharma VP; Kaur P; Ghosh SK; Yadav RS; Chauhan VS
Infect Immun; 1994 Feb; 62(2):685-91. PubMed ID: 8300225
[TBL] [Abstract][Full Text] [Related]
6. Serum antibodies from malaria-exposed people recognize conserved epitopes formed by the two epidermal growth factor motifs of MSP1(19), the carboxy-terminal fragment of the major merozoite surface protein of Plasmodium falciparum.
Egan AF; Chappel JA; Burghaus PA; Morris JS; McBride JS; Holder AA; Kaslow DC; Riley EM
Infect Immun; 1995 Feb; 63(2):456-66. PubMed ID: 7822010
[TBL] [Abstract][Full Text] [Related]
7. A longitudinal study of seroreactivities to a major blood stage antigen (Pf155/RESA) of the malaria parasite Plasmodium falciparum in an endemic area of Thailand.
Chirakalwasan N; Kamol-Ratanakul P; Lertmaharit S; Perlmann H; Perlmann P; Thaitong S
Southeast Asian J Trop Med Public Health; 1994 Mar; 25(1):25-31. PubMed ID: 7529944
[TBL] [Abstract][Full Text] [Related]
8. Lymphoproliferative responses to a merozoite surface antigen of Plasmodium falciparum: preliminary evidence for seasonal activation of CD8+/HLA-DQ-restricted suppressor cells.
Riley EM; Morris-Jones S; Taylor-Robinson AW; Holder AA
Clin Exp Immunol; 1993 Oct; 94(1):64-7. PubMed ID: 8403519
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the role of naturally acquired antibody levels to Plasmodium falciparum merozoite surface protein-1 in protecting Papua New Guinean children from malaria morbidity.
al-Yaman F; Genton B; Kramer KJ; Chang SP; Hui GS; Baisor M; Alpers MP
Am J Trop Med Hyg; 1996 May; 54(5):443-8. PubMed ID: 8644896
[TBL] [Abstract][Full Text] [Related]
10. Antibody and cellular immune responses to Plasmodium falciparum histidine-rich protein II in malaria-exposed individuals in Orissa, India.
Das P; Grewal JS; Chauhan VS
Trans R Soc Trop Med Hyg; 2010 May; 104(5):371-3. PubMed ID: 20116080
[TBL] [Abstract][Full Text] [Related]
11. IgG3 antibodies to Plasmodium falciparum merozoite surface protein 2 (MSP2): increasing prevalence with age and association with clinical immunity to malaria.
Taylor RR; Allen SJ; Greenwood BM; Riley EM
Am J Trop Med Hyg; 1998 Apr; 58(4):406-13. PubMed ID: 9574783
[TBL] [Abstract][Full Text] [Related]
12. A longitudinal study of type-specific antibody responses to Plasmodium falciparum merozoite surface protein-1 in an area of unstable malaria in Sudan.
Cavanagh DR; Elhassan IM; Roper C; Robinson VJ; Giha H; Holder AA; Hviid L; Theander TG; Arnot DE; McBride JS
J Immunol; 1998 Jul; 161(1):347-59. PubMed ID: 9647243
[TBL] [Abstract][Full Text] [Related]
13. Human immune responses to the Plasmodium falciparum ring-infected erythrocyte surface antigen (Pf155/RESA) after a decrease in malaria transmission in Madagascar.
Migot F; Chougnet C; Raharimalala L; Astagneau P; Lepers JP; Deloron P
Am J Trop Med Hyg; 1993 Mar; 48(3):432-9. PubMed ID: 8470778
[TBL] [Abstract][Full Text] [Related]
14. Naturally Acquired Antibody Responses to Plasmodium vivax and Plasmodium falciparum Merozoite Surface Protein 1 (MSP1) C-Terminal 19 kDa Domains in an Area of Unstable Malaria Transmission in Southeast Asia.
Wang Q; Zhao Z; Zhang X; Li X; Zhu M; Li P; Yang Z; Wang Y; Yan G; Shang H; Cao Y; Fan Q; Cui L
PLoS One; 2016; 11(3):e0151900. PubMed ID: 26999435
[TBL] [Abstract][Full Text] [Related]
15. Association of antibodies to Plasmodium falciparum merozoite surface protein-4 with protection against clinical malaria.
Perraut R; Varela ML; Joos C; Diouf B; Sokhna C; Mbengue B; Tall A; Loucoubar C; Touré A; Mercereau-Puijalon O
Vaccine; 2017 Dec; 35(48 Pt B):6720-6726. PubMed ID: 29042203
[TBL] [Abstract][Full Text] [Related]
16. Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1.
Egan AF; Morris J; Barnish G; Allen S; Greenwood BM; Kaslow DC; Holder AA; Riley EM
J Infect Dis; 1996 Mar; 173(3):765-9. PubMed ID: 8627050
[TBL] [Abstract][Full Text] [Related]
17. The influence of Maloprim chemoprophylaxis on cellular and humoral immune responses to Plasmodium falciparum asexual blood stage antigens in schoolchildren living in a malaria endemic area of Mozambique.
Hogh B; Thompson R; Lobo V; Dgedge M; Dziegiel M; Borre M; Gottschau A; Streat E; Schapira A; Barreto J
Acta Trop; 1994 Sep; 57(4):265-77. PubMed ID: 7810383
[TBL] [Abstract][Full Text] [Related]
18. Antibody response dynamics to the Plasmodium falciparum conserved vaccine candidate antigen, merozoite surface protein-1 C-terminal 19kD (MSP1-19kD), in Peruvians exposed to hypoendemic malaria transmission.
Torres KJ; Clark EH; Hernandez JN; Soto-Cornejo KE; Gamboa D; Branch OH
Malar J; 2008 Sep; 7():173. PubMed ID: 18782451
[TBL] [Abstract][Full Text] [Related]
19. Naturally acquired antibodies against the major merozoite surface coat protein (MSP-1) of Plasmodium falciparum acquired by residents in an endemic area of Colombia.
Terrientes ZI; Kramer K; Herrera MA; Chang SP
Mem Inst Oswaldo Cruz; 1994; 89 Suppl 2():55-61. PubMed ID: 7565133
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of the profiles of IgG subclass-specific responses to Plasmodium falciparum apical membrane antigen-1 and merozoite surface protein-1 in naturally exposed individuals living in malaria hypoendemic settings, Iran.
Rouhani M; Zakeri S; Mehrizi AA; Djadid ND
Malar J; 2015 Feb; 14():58. PubMed ID: 25652589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
